Vitamin D Deficiency in Menopausal Women Linked to Higher Atherosclerosis Risk
More than half of perimenopausal women may have vitamin D levels low enough to affect their arteries, not just their bones. A study published in Frontiers in Endocrinology examined 227 women aged 40 to 59 and found that 54.2% were vitamin D deficient. The women with lower vitamin D levels had measurably thicker arterial walls, a marker doctors use to gauge early cardiovascular risk before symptoms appear.
What the researchers measured
The study focused on carotid intima-media thickness (IMT), an ultrasound measurement of the inner two layers of the artery wall. Thicker IMT indicates early-stage atherosclerosis, the gradual narrowing of arteries caused by plaque buildup. This is not yet a heart attack or stroke, but it is the stage at which intervention is most meaningful.
Among the 227 participants, 25.6% had visible plaque formation in their carotid arteries. The statistical analysis found that each unit increase in vitamin D corresponded to a 5.5% reduction in atherosclerosis odds (OR 0.945). In practical terms: women with higher vitamin D were less likely to show arterial thickening at this stage of life.
FSH as an independent factor
The study also tracked follicle-stimulating hormone (FSH), the pituitary hormone that surges as ovarian function declines. FSH is the biological marker of menopause progression. Among participants, 76.2% had elevated FSH levels, and each unit increase in FSH corresponded to a 2.1% increase in atherosclerosis odds (OR 1.021).
This matters because the two factors operated independently. The correlation between lower vitamin D and thicker arteries held up even after FSH was accounted for, and vice versa. The researchers were not measuring the same thing twice through different proxies. Both vitamin D deficiency and elevated FSH appear to contribute to vascular risk through their own pathways.
Why this age window is critical
Estrogen plays a protective role in vascular health throughout the reproductive years, keeping arterial walls flexible and inflammation low. As estrogen declines through perimenopause, that protection fades. What the study suggests is that vitamin D may function as a partial buffer against that loss.
At the same time, the body’s ability to produce and activate vitamin D becomes less efficient with age. The skin generates less vitamin D3 from sunlight, and kidney conversion of the precursor form into active 25(OH)D slows. The result is that women at exactly the life stage when vascular protection is most needed are also the group most likely to have insufficient vitamin D status.
A blood level of 25(OH)D above 30 ng/mL is considered sufficient by most guidelines. Based on the study’s findings, 54.2% of participants were below this threshold during a period when cardiovascular risk is already increasing due to hormonal change.
What this does not tell us
The study was cross-sectional, meaning all measurements were taken at one point in time. It cannot determine whether low vitamin D caused arterial thickening, or whether both reflect some shared underlying condition. Supplementation trials would be needed to test whether correcting deficiency slows IMT progression.
The current RDA for vitamin D is 600-800 IU (15-20μg) for adults, rising to 800 IU (20μg) for those over 70. Many clinicians recommend 1,000-2,000 IU for women in midlife, particularly those with limited sun exposure or darker skin, which reduces cutaneous synthesis. Checking serum 25(OH)D is the only reliable way to determine whether supplementation is warranted.
FAQ
Q: How much vitamin D do I need daily? A: The RDA is 600-800 IU (15-20μg). Many experts recommend 1,000-2,000 IU, especially for women over 40. A blood level of 25(OH)D above 30ng/mL is considered sufficient.
Q: Why is vitamin D more important during menopause? A: After menopause, estrogen decline reduces calcium absorption and affects vascular health. Simultaneously, the skin and kidneys become less efficient at activating vitamin D, creating a double risk of deficiency.
Q: Does this study prove vitamin D prevents atherosclerosis? A: No. This was a cross-sectional study measuring one time point. It shows association, not causation. Longitudinal studies are needed to determine if supplementation prevents arterial thickening.